STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

Multiple 10b5-1 sales by insider reported for VICR (VICR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer filed Form 144 reporting multiple dispositions of Common stock by holders under prearranged plans. The excerpt lists numerous 10b5-1 sales by Patrizio Vinciarelli on dates from 04/09/2026 through 06/24/2026, with repeated single-day sales of 20,000 shares and other transactions shown. The filing lists 20,000 shares as "Securities To Be Sold" and includes smaller transfers by institutional holders on 05/14/2026. Cash‑flow treatment and proceeds recipients are described by per-transaction entries in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine, prearranged insider dispositions are shown across multiple dates.

The excerpt lists many 10b5-1 sales executed by an individual (Patrizio Vinciarelli) totaling repeated blocks of 20,000 shares on several dates between 04/09/2026 and 06/24/2026. Footnote-style rows identify transaction dates and per-trade proceeds.

These entries read as scheduled dispositions rather than ad-hoc open-market decisions; subsequent filings or a complete Form 4/144 would confirm plan details and aggregate amounts.

Series of resale entries suggest staged liquidity events by a single reporting holder.

The table shows repeated 20,000-share sales and larger dated blocks (e.g., 50,000 shares on 04/15/2026). Each row pairs a date, share count, and gross proceeds figure in dollars.

Timing and method align with entries labelled 10b5-1; aggregate impact on float is not calculable from the excerpt alone.

Securities To Be Sold 20,000 shares listed under "Securities To Be Sold"
Single-day repeated sale lot 20,000 shares multiple 10b5-1 sales on various dates between 04/09/2026 and 06/24/2026
Example proceeds (06/24/2026) $6,528,724.00 proceeds shown for 20,000 shares on 06/24/2026
Larger block example (04/15/2026) 50,000 shares 10b5-1 sale on 04/15/2026
Institutional transfers (05/14/2026) 3,500 shares Brigham and Women's Hospital and Lahey Hospital entries on 05/14/2026
10b5-1 sales regulatory
"Rows labelled "10b5-1 Sales" with dates and share counts"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Form 144 regulatory
"Header and filing type lines identifying the submission as Form 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Line reading "Founders Shares | Issuer" in the securities section"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the VICR Form 144 excerpt show about insider activity?

It shows multiple reported dispositions of Common stock, primarily 10b5-1 sales by Patrizio Vinciarelli between 04/09/2026 and 06/24/2026, with repeated 20,000-share transactions and other dated blocks.

How many shares are listed as "Securities To Be Sold" in this excerpt for VICR?

The excerpt lists 20,000 shares under the line "Securities To Be Sold." Additional per-transaction rows show many individual sale lots across April–June 2026.

Were the sales reported executed under a trading plan in the VICR excerpt?

Many rows are labelled 10b5-1 Sales, indicating transactions executed under prearranged trading plans as presented in this excerpt; full plan terms are not included here.

Does the excerpt provide proceeds amounts for each sale?

Yes. Each transaction row pairs a date and share count with a dollar figure (e.g., proceeds such as $6,528,724.00 on 06/24/2026), shown per trade in the excerpt.

Are institutional transfers included in the VICR excerpt?

Yes. The excerpt lists smaller transfers by institutions (e.g., Brigham and Women's Hospital and Lahey Hospital & Medical Center) on 05/14/2026 for 3,500 shares each.